 | Revolution Medicines, Inc. | |||
| NMS : RVMD || Location: United States | ||||
$35.12-0.47 (-1.31%) |
0.48 M | 34.69 - 35.21 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 12.000 M |
| March 15, 2024 | 16.404 M |
| Feb. 29, 2024 | 17.150 M |
| Feb. 15, 2024 | 16.959 M |
| Jan. 31, 2024 | 16.950 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.90 | -1.14 | -26.71% |
| 09/30/2023 | -1.03 | -0.99 | 3.23% |
| 06/30/2023 | -0.84 | -0.92 | -9.50% |
| 03/31/2023 | -0.83 | -0.72 | 13.23% |
| 12/31/2022 | -0.84 | -0.63 | 24.84% |
RVMD Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 164.690M | Shares Float | 160.843M |
| Short Float | 12.000M | Market Cap | 5861.32M |
| Institution ownership | 96.14% | Insider ownership | 2.456% |
| Earnings Date | 05/06/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -3.86 | Forward EPS | -3.43 |